Correlation Between ALK Abell and Zealand Pharma

Can any of the company-specific risk be diversified away by investing in both ALK Abell and Zealand Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ALK Abell and Zealand Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ALK Abell AS and Zealand Pharma AS, you can compare the effects of market volatilities on ALK Abell and Zealand Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ALK Abell with a short position of Zealand Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of ALK Abell and Zealand Pharma.

Diversification Opportunities for ALK Abell and Zealand Pharma

0.83

Correlation Coefficient

ALK Abell  Zealand Pharma

Very poor diversification

The 3 months correlation between ALK and Zealand is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding ALK Abell AS and Zealand Pharma AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zealand Pharma AS and ALK Abell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ALK Abell AS are associated (or correlated) with Zealand Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zealand Pharma AS has no effect on the direction of ALK Abell i.e., ALK Abell and Zealand Pharma go up and down completely randomly.

Pair Corralation between ALK Abell and Zealand Pharma

Assuming the 90 days trading horizon ALK Abell AS is expected to generate 0.35 times more return on investment than Zealand Pharma. However, ALK Abell AS is 2.86 times less risky than Zealand Pharma. It trades about -0.07 of its potential returns per unit of risk. Zealand Pharma AS is currently generating about -0.05 per unit of risk. If you would invest  15,910  in ALK Abell AS on December 30, 2024 and sell it today you would lose (1,560) from holding ALK Abell AS or give up 9.81% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

ALK Abell AS  vs.  Zealand Pharma AS

ALK Abell AS

Risk-Adjusted Performance

Very Weak

Over the last 90 days ALK Abell AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Zealand Pharma AS

Risk-Adjusted Performance

Very Weak

Over the last 90 days Zealand Pharma AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with ALK Abell and Zealand Pharma

The main advantage of trading using opposite ALK Abell and Zealand Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ALK Abell position performs unexpectedly, Zealand Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zealand Pharma will offset losses from the drop in Zealand Pharma's long position.

The idea behind ALK Abell AS and Zealand Pharma AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.